← Leaderboards
Abraham Wu
Sloan-Kettering Inst Can Research
$773,413
Attributed
$2,653,250
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $671.4K · FY2016–19$1M$750K$500K$250K$0
'16
'17
'18
'19
Funding mix
By agency
NIH$2,653,250 · 1
By mechanism
R01$2,653,250 · 1
Top collaborators
- John L Humm4 shared
- Kenneth H. Yu3 shared
- Nagavarakishore Pillarsetty2 shared
- Maeve Aine Lowery1 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Jayanta Chaudhuri$12,246,137
- Nancy Y Lee$8,718,881
- Richard N Kolesnick$17,601,323
- Carl Lekaye$1,309,906
- Amita Dave$3,998,296
Others in their field
Top investigators on “Deoxycytidine”
- David Heimbrook · Leidos Biomedical Research, Inc.$29,594,272
- Kenneth Schultz · Trethera Corporation$10,767,220
- Jayanta Chaudhuri · Sloan-Kettering Inst Can Research$6,788,550
- Mario Luis Santiago · University Of Colorado Denver$5,930,835
- Myron Fredric Goodman · University Of Southern California$4,415,901
- Lorraine J Gudas · Sloan-Kettering Institute For Cancer Res$4,210,723
Research focus
DeoxycytidineAcidsComputer SimulationCytosineAmerican Association Of Cancer ResearchAnalogAnimalsAntineoplastic AgentsAutoradiographyCone-Beam Computed TomographyBiodistributionBiologicalBlood VesselsCell CycleCell HypoxiaCell ProliferationCellsChemoradiationClinically RelevantClinical ProtocolsClinical ResearchAftercareClinical TrialsDependence
Grant awards (4)
Imaging drug uptake and distribution in chemoradiation therapy of pancreatic cancer$671,441
R01 · FY2019 · CA
Imaging drug uptake and distribution in chemoradiation therapy of pancreatic cancer$660,603
R01 · FY2018 · CA
Imaging drug uptake and distribution in chemoradiation therapy of pancreatic cancer$660,603
R01 · FY2017 · CA
Imaging drug uptake and distribution in chemoradiation therapy of pancreatic cancer$660,603
R01 · FY2016 · CA